Weild IV David 4
4 · BioSig Technologies, Inc. · Filed Nov 9, 2018
Insider Transaction Report
Form 4
Weild IV David
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-10-16+69,132→ 69,132 totalExercise: $5.09Exp: 2028-10-16→ Common Stock (69,132 underlying)
Footnotes (1)
- [F1]One-fourth (1/4) of the option vested on October 16, 2018 and the remainder will vest as follows: (i) one-fourth (1/4) will vest on January 1, 2019; (ii) one-fourth (1/4) will vest on January 1, 2020; and (iii) one-fourth (1/4) will vest on January 1, 2021.